Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
24 studies found for:    10-i-0004
Show Display Options
Rank Status Study
1 Completed VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years
Condition: Influenza, Human
Intervention: Biological: VRC-FLUDNA056-00VP
2 Completed Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
Condition: HIV Infection
3 Terminated Sensorimotor Based Brain Computer Interface
Condition: Healthy Volunteers
Intervention: Other: Brain computer Interface Mu (SMR) rhythm
4 Completed
Has Results
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Conditions: Prostatic Neoplasms;   Metastases, Neoplasm
Interventions: Drug: ZD4054 10 mg;   Drug: ZD4054 15 mg;   Drug: ZD4054 22.5 mg
5 Completed S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: tirapazamine;   Radiation: radiation therapy
6 Recruiting An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: BG00012 (dimethyl fumarate)
7 Recruiting A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021)
Condition: Non-small Cell Lung Carcinoma
Interventions: Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Biological: Bevacizumab;   Drug: Pemetrexed;   Biological: Ipilimumab;   Drug: Erlotinib;   Drug: Gefitinib
8 Completed Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma;   Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Contiguous Stage II Mantle Cell Lymphoma;   Contiguous Stage II Marginal Zone Lymphoma;   Contiguous Stage II Small Lymphocytic Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Noncontiguous Stage II Marginal Zone Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Adult Diffuse Small Cleaved Cell Lymphoma;   Stage I Grade 1 Follicular Lymphoma;   Stage I Grade 2 Follicular Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage I Marginal Zone Lymphoma;   Stage I Small Lymphocytic Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Small Lymphocytic Lymphoma;   Waldenström Macroglobulinemia
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Biological: filgrastim;   Radiation: yttrium Y 90 ibritumomab tiuxetan;   Procedure: peripheral blood stem cell transplantation
9 Recruiting A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
Condition: Schizophrenia
Interventions: Drug: BI 409306 100 mg QD;   Drug: BI 498306 50 mg QD;   Drug: Placebo;   Drug: BI 498306 25 mg QD;   Drug: BI 409306 10 mg QD
10 Completed
Has Results
Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers
Conditions: Congenital Bleeding Disorder;   Healthy
Interventions: Drug: vatreptacog alfa (activated);   Drug: placebo
11 Completed
Has Results
Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
Condition: Manic or Mixed Episode Associated With Bipolar I Disorder
Interventions: Drug: olanzapine;   Drug: lithium;   Drug: valproate;   Drug: carbamazepine
12 Recruiting A Study of LY3002813 in Participants With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: LY3002813-IV;   Biological: LY3002183-SC;   Drug: Placebo-IV
13 Completed
Has Results
VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
Condition: HIV Infections
Interventions: Drug: nevirapine IR;   Drug: nevirapine XR
14 Active, not recruiting A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)
Condition: Schizophrenia
Interventions: Drug: bitopertin [RO4917838];   Drug: Placebo
15 Completed Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: midazolam;   Drug: BI 201335;   Drug: tenofovir;   Drug: caffeine;   Drug: tolbutamide;   Drug: pegylated interferon;   Drug: BI 207127;   Drug: ribavirin
16 Completed A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
Conditions: Postherpetic Neuralgia (PHN);   Peripheral Nerve Injury (PNI);   Non-diabetic Painful Peripheral Polyneuropathy
Interventions: Drug: Qutenza;   Drug: Pregabalin
17 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature
Interventions: Drug: Niacin;   Drug: Placebo
18 Active, not recruiting A Study in Participants With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Baricitinib;   Drug: Methotrexate;   Drug: Placebo;   Drug: Folic Acid
19 Unknown  Trial of exSALT SD7™ Compared to Xeroform® Petrolatum Dressing for the Management of Partial Thickness Donor Sites
Conditions: Wound Healing;   Wound Infection
Interventions: Device: The exSALT™ SD7 Wound Dressing;   Device: Xeroform® Petrolatum Dressing
20 Recruiting A Study of Pembrolizumab (MK-3475) in Combination With Lenalidomide and Dexamethasone in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Condition: Multiple Myeloma
Interventions: Biological: Pembrolizumab;   Drug: Lenalidomide;   Drug: Dexamethasone

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years